SCHEMBL23730868

SCHEMBL23730868

c1ccc(-c2cc(-c3ccc(-c4cc(-c5cccc(-c6cc(-c7ccccc7)nc(-c7ccccc7)n6)c5)c5sc6ccccc6c5c4)cc3)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.43
MEN1 O00255 8/20 0.43
KMT2A Q03164 8/20 0.43
MAPT P10636 6/20 0.43
ALDH1A1 P00352 5/20 0.43
HPGD P15428 5/20 0.43
KDM4E B2RXH2 3/20 0.43
LMNA P02545 2/20 0.43
GLA P06280 1/20 0.43
NTSR1 P30989 1/20 0.41
TNKS O95271 1/20 0.38
TNKS2 Q9H2K2 1/20 0.38
MAOB P27338 3/20 0.36
MAOA P21397 2/20 0.36
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
LIMK1 P53667 1/20 0.36
NPSR1 Q6W5P4 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23730706 0.96 MEN1 (0.43) ALOX5MEN1KMT2AMAPTALDH1A1
SCHEMBL23730818 0.96 MEN1 (0.42) ALOX5MEN1KMT2AMAPTALDH1A1
SCHEMBL23730700 0.94 MEN1 (0.42) ALOX5MEN1KMT2AMAPTALDH1A1
SCHEMBL23730845 0.94 MEN1 (0.44) ALOX5MEN1KMT2AMAPTALDH1A1
SCHEMBL23731099 0.93 MEN1 (0.41) ALOX5MEN1KMT2AMAPTALDH1A1
SCHEMBL17425450 0.91 ALOX5 (0.46) ALOX5MEN1KMT2AMAPTALDH1A1
SCHEMBL23730938 0.90 MEN1 (0.47) ALOX5MEN1KMT2AMAPTALDH1A1
SCHEMBL17425694 0.90 ALOX5 (0.44) ALOX5MEN1KMT2AMAPTALDH1A1
SCHEMBL23848353 0.89 ALOX5 (0.53) ALOX5MEN1KMT2AMAPTALDH1A1
SCHEMBL17775871 0.89 ALOX5 (0.53) ALOX5MEN1KMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11081655-B2 Heterocyclic compound and organic light emitting device using the same LG CHEM, LTD. (KR) 2021-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11081655-B2 Heterocyclic compound and organic light emitting device using the same CRY1, CYP1B1, CYBA ALOX5 328/4885MEN1 575/4885KMT2A 2218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.